Cheek cell FA composition | Cheek cell FA correlation | |||||||
---|---|---|---|---|---|---|---|---|
Reference | Connor et al.(2000)[20] | Staps and Kuhnt (2010)[unpublished] | Klingler et al.(2013)[11] | Present study | Klingler et al.(2013)[11] | Present study | ||
Study group | Control group | Total subjects; baseline values | Total subjects; baseline values | Total subjects; baseline values | Total subjects; baseline values | Total subjects; baseline values | ||
Subjects | Infants | Adults | Adults | Adults | Adults | Adults | ||
(n = 8) | (n = 4) | (n = 13) | (n = 38) | (n = 13) | (n = 38) | |||
Lipid class | Phospholipids | Total lipids | Glycerophospholipids | Total lipids | Glycerophospholipids | Total lipids | ||
% FAME | % FAME | mol% | % FAME | r 1 Plasma | r 1 RBC | r 1 Plasma | r 1 RBC | |
SFA | ||||||||
C16:0 | 14.5 | 15.6 | 16.6 | 17.1 | 0.64* | 0.32 | -0.08 | -0.10 |
C18:0 | 12.3 | 11.4 | 15.3 | 16.5 | 0.70** | 0.33 | 0.04 | -0.16 |
n-9 MUFA | ||||||||
C18:1n-9 (OA) | 25.8 | 28.9 | 30.1 | 26.7 | 0.40 | 0.10 | 0.34* | 0.06 |
n-6 PUFA | ||||||||
C18:2n-6 (LA) | 16.5 | 18.4 | 17.3 | 17.1 | -0.04 | -0.05 | -0.59 | 0.21 |
C20:4n-6 (AA) | 2.00 | 4.37 | 3.20 | 3.32 | 0.65** | 0.17 | 0.54*** | 0.54*** |
C22:5n- 6 | 1.00 | 0.12 | 0.07 | 0.06 | 0.78*** | 0.70** | 0.52*** | 0.58*** |
n-3 PUFA | ||||||||
C18:3n-3 (ALA) | 0.40 | 0.23 | 0.24 | 0.29 | 0.11 | 0.13 | 0.17 | 0.06 |
C20:5n-3 (EPA) | 0.10 | 0.55 | 0.21 | 0.22 | 0.66 | 0.79** | 0.81*** | 0.82*** |
C22:5n-3 (DPA) | 0.20 | 0.43 | 0.23 | 0.22 | 0.85 | 0.39 | 0.73*** | 0.67*** |
C22:6n-3 (DHA) | 0.40 | 1.07 | 0.69 | 0.79 | 0.76*** | 0.88*** | 0.68*** | 0.64*** |